HUMA

NASD Humacyte, Inc.
Nov 5, 2026 · 9:20 AM ET LAST TRADE Market Closed

$0.4499 ↓ -0.0001 (-0.02%) Trading Down from the previous close of $0.4500

YTD change
-53.16%
vs 20-day SMA
+7.41%
vs 200-day SMA
-43.55%

Price ranges

Previous day
$0.4247 $0.4750
open $0.4598 close $0.4500
-$0.0098 (-2.13%)
Today
$0.0000 $0.0000
$0.4499
Past week
$0.3850 $0.5100
from $0.4701 now $0.4499
-$0.0202 (-4.30%)
Past month
$0.3370 $0.5100
from $0.4723 now $0.4499
-$0.0224 (-4.74%)
This year
$0.3370 $1.5250
from $0.9605 now $0.4499
-$0.5106 (-53.16%)

Price & Performance

-0.45 (-50.11%) / 6M

$0.2632$0.7024$1.14$1.58May 5Aug 5Nov 4

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Neutral
  • The stock is 97.4% away from all-time highs of $17.4500
  • HUMA is down 53% since the beginning of the year
  • HUMA is down 69% over the past 12 months
  • HUMA is down 5% over the past 1 month
  • 11% of all HUMA investors are betting against HUMA

HUMA reads neutral: price sits above one of the two key moving averages, the 12-month move is -69.0%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable No
EPS $-0.16
Earnings momentum -65.4% Quarterly EPS growth
Quarterly change -65.4%

Valuation

P/E ratio N/A
Enterprise value $91.5M
Beta 4.75

Balance sheet & scale

IncomeN/A
Revenue$2.1M
Cash$80.0M
Debt$66.2K
Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNASD
Sector Professional, Scientific, and Technical Services
Industry Group Scientific Research and Development Services
Market cap $125.0M

Humacyte, Inc. engages in the business of developing and manufacturing off-the-shelf, universally implantable, bioengineered human tissues, advanced tissue constructs, and organ systems with the goal of improving the lives of patients and transforming the practice of medicine. The company was founded by Laura E. Niklason, Shannon Dahl, and Juliana L. Blum on October 13, 2004 and is headquartered in Durham, NC.

Competitor comparison

TickerCompany PriceChange
AMGN Amgen Inc. $478.48 +3.73%
MRNA Moderna, Inc. $258.38 +13.11%
RVMD Revolution Medicines, Inc. $199.70 +2.82%
ROIV Roivant Sciences Ltd. $38.23 +6.08%
BNTX BioNTech SE Sponsored ADR $90.70 +4.35%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.